QURE Jan 2024 15.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:17PM EST. Market open.
| Previous close | 0.0500 |
| Open | 0.0500 |
| Bid | 0.0000 |
| Ask | 2.4000 |
| Strike | 15.00 |
| Expiry date | 2024-01-19 |
| Day's range | 0.0500 - 0.0500 |
| Contract range | N/A |
| Volume | |
| Open interest | 1k |
Simply Wall St.Shareholders in uniQure (NASDAQ:QURE) are in the red if they invested three years ago
uniQure N.V. ( NASDAQ:QURE ) shareholders should be happy to see the share price up 24% in the last month. But that...
GlobeNewswireuniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for Fabry Disease
Patient enrollment expected to begin in first half of 2024LEXINGTON, Mass. and AMSTERDAM, Nov. 29, 2023 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for AMT-191, the Company’s gene therapy candidate for Fabry disease. AMT-191 comprises an AAV5 vector that delivers a
- Simply Wall St.
Calculating The Fair Value Of uniQure N.V. (NASDAQ:QURE)
Key Insights The projected fair value for uniQure is US$7.03 based on 2 Stage Free Cash Flow to Equity Current share...
© 2023 Yahoo. All rights reserved.